Glyxambi 25/5 is a topic covered in the Davis's Drug Guide.
To view the entire topic, please log in or purchase a subscription.
Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Vallerand, April Hazard., et al. "Glyxambi 25/5." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110216/all/Glyxambi_25_5.
Vallerand AHA, Sanoski CAC, Quiring CC. Glyxambi 25/5. Davis's Drug Guide. F.A. Davis Company; 2023. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110216/all/Glyxambi_25_5. Accessed March 21, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Glyxambi 25/5. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110216/all/Glyxambi_25_5
Vallerand AHA, Sanoski CAC, Quiring CC. Glyxambi 25/5 [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 March 21]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110216/all/Glyxambi_25_5.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Glyxambi 25/5 ID - 110216 A1 - Sanoski,Cynthia A, AU - Vallerand,April Hazard, AU - Quiring,Courtney, BT - Davis's Drug Guide UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110216/all/Glyxambi_25_5 PB - F.A. Davis Company ET - 18 DB - Medicine Central DP - Unbound Medicine ER -